Novel roles for chemokines and fibroblasts in interstitial fibrosis

Kidney International

Volumn 54, Issue 6, 1998, Pages 2152-2159

  Hogaboam, Cory M ^a   Steinhauser, Matthew L ^a   Chensue, Stephen W ^a   Kunkel, Steven L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Fibrotic disease; Immune response; Inflammation; Injury; Tissue repair; Wound healing

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

CONFERENCE PAPER; CYTOKINE PRODUCTION; FIBROBLAST CULTURE; FIBROGENESIS; HUMAN; INFLAMMATION; KIDNEY FIBROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031756118     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00176.x     Document Type: Conference Paper

References (64)

1. WEISSLER JC: Idiopathic pulmonary fibrosis: Cellular and molecular pathogenesis. Am J Med Sci 297:91-104, 1989
2. MEDURI GU, HEADLEY S, KOHLER G, STENTZ F, TOLLEY E, UMBERGER R, LEEPER K: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107:1062-1073, 1995
3. SCHWARTZ MI: Interstitial pulmonary fibrosis, in Textbook of Internal Medicine, edited by KELLEY WN, Philadelphia, J.P. Lippincott, 1989, pp 1902-1905
4. GOLDRING MB, SANDELL LJ, STEPHENSON ML: Immune interferon suppresses levels of procollagen mRNA and type Ii collagen synthesis in articular and costal chondrocytes. J Immunol 261:9049-9056, 1986
5. DUNCAN MR, BERMAN B: Gamma interferon is the lymphokine and beta interferon is the monokine responsible for the inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 162:516-527, 1985
6. SEMPOWSKI GD, BECKMANN MP, DERDAK S, PHIPPS RP: Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 152:3606-3614, 1994
7. POSTLETHWAITE AE, HOLNESS MA, KATAI H, RAGHOW R: Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin-4. J Clin Invest 90:1479-1485, 1992
8. POSTLETHWAITE AE, SEYER JM: Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. J Clin Invest 87:2147-2152, 1991
9. MOSMANN TR, MOORE KW: The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol Today 12:49-53, 1991
10. PLAUT M, PIERCE JH, WATSON CJ, HANLEY-HYDE J, NORDAN RP, PAUL WE: Mast cell lines produce lymphokines in response to crosslinking FcER1 or to calcium ionophores. (abstract) Nature 339:64, 1989
11. CHENSUE SW, WARMINGTON K, RUTH J, LINCOLN P, Kuo M-C, KUNKEL SL: Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol 145:1105-1113, 1994
12. CHENSUE SW, TEREBUH PD, WARMINGTON KS, HERSHEY SD, EVANOFF HL, KUNKEL SL, HIGASHI GI: Role of IL-4 and IFN in Schistosoma mansoni egg-induced hypersensitivity granuloma formation. Orchestration, relative contribution, and relationship to macrophage function. J Immunol 148:900-906, 1992
13. LUKACS NW, ADDISON C, GAULDIE J, GRAHAM F, SIMPSON K, STRIETER RM, WARMINGTON K, CHENSUE SW, KUNKEL SL: Transgene-induced production of IL-4 alters the development and collagen expression of T helper cell 1-type pulmonary granulomas. J Immunol 158:4478-4484, 1997
14. CHENSUE SW, WARMINGTON K, RUTH JH, LUKACS N, KUNKEL SL: Mycobacterial and Schistosomal antigen-elicited granuloma formation in IFNgamma and IL-4 knockout mice. Analysis of local and regional cytokine and chemokine networks. J Immunol 159:3563-3573, 1997
15. KUNKEL SL, LUKACS N, STRIETER RM: Chemokines and their role in human disease. Agents Actions 46(Suppl):11-22, 1995
16. JOSE PJ, GRIFFITHS-JOHNSON DA, WALSH DT, MOQBEL R, TOTTY NF, TRUONG O, HSUAN JJ, WILLIAMS TJ: Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J Exp Med 179:881-887, 1994
17. HEDRICK JA, ZLOTNICK A: Identification and characterization of a novel Beta chemokine containing six conserved cysteines. J Immunol 159:1589-1593, 1997
18. PREMACK BA, SCHALL TJ: Chemokine receptors: Gateways to inflammation and infection. Nature Med 2:1174-1178, 1996
19. CHENSUE SW, WARMINGTON KS, RUTH JH, SANGHI PS, LINCOLN PM, KUNKEL SL: Role of monocyte chemoattractant protein-1 in Th1 (Mycobacterial) and Th2 (Schistosomal) antigen-induced granuloma formation: Relationship to local inflammation, Th cell expression and IL-12 production. J Immunol 157:4602-4608, 1996
20. KARPUS WJ, LUKACS NW, KENNDEY KJ, SMITH WS, HURST SD, BARRETTA: Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158:4129-4136, 1997
21. LUKACS NW, CHENSUE SW, KARPUS WJ, LINCOLN P, KEEFER C, STRIETER RM, KUNKEL SL: C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am J Pathol 150:1861-1868, 1997
22. HOGABOAM CM, LUKACS NW, CHENSUE SW, STRIETER RM, KUNKEL SL: Monocyte chemoattractant protein-1 synthesis by murine lung fibroblasts modulates CD4+ T cell activation. J Immunol 160:4606-4614, 1998
23. Lu B, RUTLEDGE BJ, Gu L, FIORILLO J, LUKACS NW, KUNKEL SL, NORTH R, GERARD C, ROLLINS BJ: Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein-1-deficient mice. J Exp Med 187:601-608, 1998
24. LYNCH JP, STANDIFORD TJ, ROLFE MW, KUNKEL SL, STRIETER RM: Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of IL-8. Am Rev Respir Dis 145:1433-1439, 1992
25. KHANE MP, ARENBERG DA, LYNCH JPR, WHYTE RI, IANNETTONI MD, BURDICK MD, WILKE CA, MORRIS SB, GLASS MC, DIGIOVINE B, KUNKEL SL, STRIETER RM: The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 159:1437-1443, 1997
26. PETREK M, PANTELIDIS P, SOUTHCOTT AM, LYMPANY P, SAFRANEK P, BLACK CM, KOLEK V, WEIGL E, DU BOIS RM: The source and role of RANTES in interstitial lung disease. Eur Repir J 10:1207-1216, 1994
27. ANTONIADES HN, NEVILLE-GOLDEN J, GALANOPOULOS T, KRADIN RL, VALENTE AJ, GRAVES DT: Expression of monocyte chemoattractant protein-1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 89:5371-5375, 1992
28. STANDIFORD TJ, ROLFE MR, KUNKEL SL, LYNCH JPD, BECKER FS, ORRINGER MB, PHAN S, STRIETER RM: Altered production and regulation of monocyte chemoattractant protein-1 from pulmonary fibroblasts isolated from patients with idiopathic pulmonary fibrosis. Chest 103(Suppl 2):121S, 1993
29. STANDIFORD TJ, ROLFE MW, KUNKEL SL, LYNCH JP, BURDICK M, GILBERT AR, ORRINGLR MB, WHYTE RI, STRIETER RM: Macrophage inflammatory protein-1 alpha expression in interstitial lung disease. J Immunol 151:2852-2863, 1993
30. BRIELAND JK, JONES ML, FLORY CM, MILLER GR, WARREN JS, PHAN SH, FANTONE JC: Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury. Am J Respir Cell Mol Biol 9:300-305, 1993
31. ZHANG K, GHARAEE-KERMANI M, JONES ML, WARREN JS, PHAN SH: Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 153:4733-4741, 1994
32. LLOYD CM, MINTO AW, DORF ME, PROUDFOOT A, WELLS TN, SALANT DJ, GUTIERREZ-RAMOS JC: RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 185:1371-1380, 1997
33. SMITH RE, STRIETER RM, PHAN SH, KUNKEL SL: C-C chemokines: Novel mediators of the profibrotic inflammatory response to bleomycin challenge. Am J Respir Cell Mol Biol 15:693-702, 1496
34. GHARAEE-KERMANI M, DENHOLM EM, PHAN SH: Costimulation of fibroblast collagen and transforming growth factor betal gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 271:17779-17784, 1996
35. JORDANA M: Mast cells and fibrosis - Who's on first? Am J Respir Cell Mol Biol 8:7-8, 1993
36. SHULL MM, ORMSBY I, KIER AB, PAWLOWSKI S, DIEBOLD RJ, YIN M, ALLEN R, SIDMAN C, PROETZL G, CALVIN D, ANNUNZIATA N, DOETSCHMAN T: Targeted disruption of the mouse transforming growth factor-betal gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
37. TAUB DD, OPPENHEIM JJ: Chemokines, inflammation and the immune system. Ther Immunol 1:229-246, 1994
38. LUKACS NW, KUNKEL SL, ALLEN R, EVANOFF HL, SHAKLEE CL, SHERMAN JS, BURDICK MD, STRIETER RM: Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations. Am J Physiol 268(5 Pt 1):L856-L861, 1995
39. XIA Y, PAUZA ME, FENG L, LO D: RelB regulation of chemokine expression modulates local inflammation. Am J Pathol 151:375-387, 1997
40. NAGAOKA I, TRAPNELL BC, CRYSTAL RG: Up-regulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest 85:2023-2027, 1990
41. ANTONIADES HN, BRAVO MA, AVILA RE, GALANOPOULOS T, NEVILLE-GOLDEN J, MAXWELL M, SELMAN M: Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 86:1055-1064, 1990
42. MCKEE CM, PENNO MB, COWMAN M, BURDICK MD, STRIETER RM, BAO C, NOBLE PW: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 98:2403-2413, 1996
43. CARRE PC, MORTENSON RL, KING TE, NOBLE PW, SABLE CL, RICHES DW: Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 88:1802-1810, 1991
44. STEINHAUSER ML, KUNKEL SL, HOGABOAM CM, EVANOFF H, STRIETER RM, LUKACS NW: Macrophage/fibroblast co-culture induces macrophage inflammatory protein-1alpha production mediated by intercellular adhesion molecule-1 and oxygen radicals. J Leuk Biol (in press)
45. VATH RR, ALEXANDER CB, FULMER JD: The lymphocytic infiltrative lung diseases. Clin Chest Med 3:619-634, 1982
46. POSTLETHWAITE AE, SMITH GN, MAINARDI CL, SEYER JM, KANG AH: Lymphocyte modulation of fibroblast in vitro: Stimulation and inhibition of collagen production by different effector molecules. J Immunol 132:2470-2477, 1984
47. MONROE JG, HALDAR S, PRYSTOWSKY MB, LAMMIE P: Lymphokine regulation of inflammatory processes: Interleukin-4 stimulates fibroblast proliferation. Clin Immunol Immunopathol 49:292-298, 1988
48. BOMBARA MP, WEBB DL, CONRAD P, MARLOR CW, SARR T, RANGES GE, AUNE TM, GREVE JM, BLUE ML: Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. J Leuk Biol 54:399-406, 1993
49. CARR MW, ALON R, SPRINGER TA: The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes. Immunity 4:179-187, 1996
50. AGIUS RM, GODFREY RC, HOLGATE ST: Mast cell and histamine content of human bronchoalveolar lavage fluid. Thorax 40:760-767, 1985
51. CLAMAN HN: Mast cells and fibrosis. Rheum Dis Clin North Am 16:141-151, 1990
52. GRIFFITHS-JOHNSON DA, COLLINS PD, ROSSI AG, JOSE PJ, WILLIAMS TJ: The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation in vivo. Biochem Biophys Res Commun 197:1167-1172, 1993
53. ROTHENBERG ME, LUSTER AD, LEDER P: Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 92:8960-8964, 1995
54. HALLGREN R, BJERMER L, LUNDGREN R, VENGE P: The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung is associated with impaired lung function. Am Rev Resp Dis 139:373-383, 1989
55. NOGUCHI H, KEPHART GM, COLBY TV, GLEICH GJ: Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 140:521-528, 1992
56. FUJIMOTO K, KUBO K, YAMAGUCHI S, HONDA T, MATSUZAWA Y: Eosinophil activation in patients with pulmonary fibrosis. Chest 108: 48-54, 1995
57. PETERSON MW, MONICK M, HUNNINGHAKE GW: Prognostic role of eosinophils in pulmonary fibrosis. Chest 92:51-56, 1987
58. ENRIGHT T, CHUA S, LIM DT: Pulmonary eosinophilic syndromes. Ann Allergy 62:277-283, 1989
59. ZHANG K, GHARAEE-KERMANI M, MCGARRY B, REMICK D, PHAN SH: TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J Immunol 158:954-959, 1997
60. SHOCK A, RABE KF, DENT G, CHAMBERS RC, GRAY AJ, CHUNG KF, BARNES PJ, LAURENT GJ: Eosinophils adhere to and stimulate replication of lung fibroblasts in vitro. Clin Exp Immunol 86:185-190, 1991
61. BIRKLAND TP, CHEAVENS MD, PINCUS SH: Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts. Arch Dermatol Res 286:312-318, 1994
62. VANCHERI C, GAULDIE J, BIENENSTOCK J, COX G, SCICCHITANO R, STANISZ A, JORDANA M: Human lung fibroblast-derived granulocyte macrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro. Am J Respir Cell Mol Biol 1:289-295, 1989
63. LANG JM, HOPPE J, WILLIAMS JD, TOPLEY N.: Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 51:205-215, 1997
64. JÖRRES A, LUDAT K, LANG J, SANDER K, GAHL, GM, FREI U, DEJONGE K, WILLIAMS JD TOPLEY N: Establishment and functional characterisation of human peritoneal fibroblasts in culture: Induction of IL-6 synthesis by macrophage-derived cytokines J Am Soc Nephrol 7:2192-2201, 1996